Call for Announcements: 28th International Conference on Neuropharmacology and Neurochemistry

 May 22-23, 2023 | Vienna, Austria
28th International Conference on Neuropharmacology and Neurochemistry
https://neuropharmaceutics.conferenceseries.com/

The 28th International Conference on Neuropharmacology and Neurochemistry, which will be held on May 22-23, 2023, is cordially invited to attend. "Current Scenario and Future Approach in Neuropharmaceutics" will be the theme of the conference. The Neuropharmacology and Neurochemistry conference is a specific discussion that brings innovative methods and also brings together renowned Researchers and academicians concerned with neurology, neuroscience, and cognition, as well as Psychiatrist specialists, Public health professionals, Neuroscientists, and Specialists to trade about innovative research and innovations. This conference will provide advanced Neuropharmacology and Neurochemistry knowledge. The goal of the conference is to provide a forum for Scholastics and specialists from various disciplines to discuss the social change in an age of technology and innovation. It is the best opportunity for global knowledge expansion.

All attendees, presenters, sponsors, and exhibitors at Neuropharmaceutics 2023 are cordially welcomed and invited. We cordially invite you to sign up for the 28th International Conference on Neuropharmacology and Neurochemistry and to participate. We cordially invite you to the Neuropharmacology and Neurochemistry conference, where you can meet academics from all over the world and engage in meaningful conversations. The conference will feature timely keynote presentations, oral talks, poster presentations, and exhibitions. Internationally known experts in the domains of neuropharmacology and neurochemistry, as well as researchers in the fields of the brain and public health, as well as academic and corporate researchers in the field of Neuropharmaceutics, will be gathered at the conference Neuropharmaceutics 2023.

Why attend?

Neuropharmaceutics 2023 will bring together internationally renowned academics in the fields of neuropharmacology and neurochemistry, brain researchers, public health professionals, neuroscientists, neuro academic scientists, industry researchers, and neuro scholars.

• To Meet Experts
• Learning In a New Space
• New Tips & Tactics
• Certification
• Global Networking
• Rebuild New Customer Base
• Brand Establishment

Market analysis -

According to the Global Burden of Disease 2015 study, there are currently about 6.2 million individuals worldwide who have Parkinson's disease, and by the year 2040, there will be about 13 million. Additionally, the Parkinson's Disease Foundation reports that each year, almost 60,000 Americans are given a Parkinson's disease diagnosis as a result, there will likely be a significant increase in demand for neuromodulation devices, which will help the global market grow. A few other factors contributing to the high CAGR of the market globally include the increase in research efforts to broaden the application of neuromodulation and growing public awareness of the effectiveness and safety of neurostimulator devices. However, over the forecast period of 2020–2027, the availability of skilled healthcare professionals and the high cost of neuromodulation procedures will be the main barriers to market growth.

The Parkinson's Disease market offers anti-Parkinson medications. Drug classes and geographic areas make up the market divisions. Drug classes are used to categorize the market for dopamine agonists, inhibitors, and other anti-Parkinson drugs. North America, Europe, Asia-Pacific, South America, the Middle East, and Africa make up the segmented market.

Neuropharmaceutics 2023 Organizing Committee members –

Barrett Katz

Professor
Albert Einstein College of Medicine
USA

Mohamed Fahmy Zeid

Prof Dr.
Neurosurgery Department, Faculty of Medicine, Alexandria University & President Of Egyptian Society of Brain and Skull,
Egypt

Neuropharmaceutics Conference Secretariat at:  neuropharmaceutics@meetingsemail.com More information concerning Neuropharmaceutics Conference and its scientific, organization, and Registration can be found at: https://neuropharmaceutics.conferenceseries.com/registration.php

Conference Contact Details:

Alev Bell 
Program Manager | Neuropharmaceutics  2023
WhatsApp no - +44- 7915638336
Toll-Free Number: 0800-014-8923
Email - neuropharmaceutics@meetingsemail.com